title: Cardiovascular and renal complications in patients with resistant hypertension.
abstract: With an increased prevalence, resistant hypertension is recognized as an entity with a high cardiovascular morbidity and mortality. In a large cohort of patients with resistant hypertension, the crude incidence rate of total cardiovascular events reached 4.32 per 100 patient-years of follow-up (19.6 %), with a cardiovascular mortality of 8.3 % (incidence rate of 1.72 per 100 patient-years). Cardiovascular event rates are significantly higher in resistant hypertensives compared with non-resistant (18.0 % versus 13.5 %). In the same way, the prevalence of established cardiovascular and renal disease, as the asymptomatic organ damage (represented by left ventricular hypertrophy, carotid wall thickening, arterial stiffness, and microalbuminuria) is higher in these patients. Many studies have demonstrated a strong association between damage to these organs with higher blood pressure levels, the diagnosis of true resistant hypertension, and refractory hypertension. All efforts should be employed in order to control blood pressure and also to regress and/or prevent subclinical cardiovascular and renal damage. The focus should be on prevention of cardiovascular and renal complications, improving the prognosis of resistant hypertension.
authors: Department of Internal Medicine, University Hospital Clementino Fraga Filho, Medical School, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, bethmux@globo.com.
authors: Elizabeth S
authors: ES
authors: Muxfeldt
authors: Fabio
authors: F
authors: de Souza
authors: Victor S
authors: VS
authors: Margallo
authors: Gil F
authors: GF
authors: Salles
mesh_terms: D001794:Blood Pressure / Q000502:physiology*; D014943:Global Health; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D007674:Kidney Diseases / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors